Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

493
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
493
Tumor Immunotherapy01:27

Tumor Immunotherapy

643
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Vaccinations01:51

Vaccinations

45.2K
Overview
45.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure and mechanism of inhibition of lysine demethylase 2A (KDM2A) by compound 183c.

Communications chemistry·2026
Same author

Comparative Evaluation of HPV PLUS ELITe MGB® and Allplex™ HPV HR Assays for High-Risk Human Papillomavirus Genotyping in Cervical Samples.

Journal of medical virology·2026
Same author

Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing.

The Journal of antimicrobial chemotherapy·2026
Same author

Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan France.

Viruses·2026
Same author

Use of Maribavir in Adult Patients With Post-Transplant Refractory Cytomegalovirus Infection in the Real-Life Setting.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

The SCANVIR<sup>®</sup> Project: A Success in Hepatitis C Micro-Elimination in Nouvelle-Aquitaine.

Viruses·2026

Related Experiment Video

Updated: Aug 27, 2025

Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.5K

[Therapeutic HPV vaccines].

Sébastien Hantz1, Sophie Alain1, François Denis1

  • 1CHU de Limoges, laboratoire de bactériologie-virologie-hygiène, 2, avenue Martin-Luther-King, 87042 Limoges, France.

Virologie (Montrouge, France)
|September 24, 2022
PubMed
Summary

Therapeutic vaccines targeting human papillomavirus (HPV) show promise for cervical cancer, but current strategies need refinement. Future approaches may involve earlier intervention and combination therapies for improved outcomes.

Keywords:
HPVcervical cancerclinical trialsimmunotherapytherapeutic vaccine

More Related Videos

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

1.9K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.6K

Related Experiment Videos

Last Updated: Aug 27, 2025

Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.5K
Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

1.9K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.6K

Area of Science:

  • Oncology
  • Immunology
  • Virology

Context:

  • Cervical cancer remains a global health issue despite advances in prevention and treatment.
  • Cervical cancer development is linked to human papillomavirus (HPV) oncogenes E6 and E7.
  • HPV oncoproteins are attractive targets for therapeutic vaccine development.

Purpose:

  • To review the current landscape of therapeutic vaccine strategies for cervical dysplasia and cancer.
  • To evaluate the efficacy and limitations of existing vaccine approaches.
  • To propose future directions for enhancing therapeutic vaccine effectiveness.

Summary:

  • Various vaccine platforms, including viral vectors, proteins, peptides, DNA, and cell-based therapies, have been explored.
  • Clinical trials have primarily targeted precancerous lesions and established cancers.
  • While T-cell responses are often induced, therapeutic vaccine success has been limited.

Impact:

  • Refining vaccination strategies is crucial for improving cervical cancer treatment.
  • Future vaccines may benefit from earlier application in the disease continuum.
  • Combination therapeutic vaccine strategies hold potential for enhanced clinical outcomes.